HomeCompareLUMO vs ADC

LUMO vs ADC: Dividend Comparison 2026

LUMO yields 46.08% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LUMO wins by $142.3K in total portfolio value
10 years
LUMO
LUMO
● Live price
46.08%
Share price
$4.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$321.2K
Annual income
$60,965.20
Full LUMO calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — LUMO vs ADC

📍 LUMO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLUMOADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LUMO + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LUMO pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LUMO
Annual income on $10K today (after 15% tax)
$3,917.05/yr
After 10yr DRIP, annual income (after tax)
$51,820.42/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, ADC beats the other by $16,857.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LUMO + ADC for your $10,000?

LUMO: 50%ADC: 50%
100% ADC50/50100% LUMO
Portfolio after 10yr
$250.1K
Annual income
$70,881.25/yr
Blended yield
28.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

LUMO
No analyst data
Price Target
$16.50
+280.2% upside vs current
Range: $7.00 — $26.00
Altman Z
-19.2
Piotroski
3/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LUMO buys
0
ADC buys
0
No recent congressional trades found for LUMO or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLUMOADC
Forward yield46.08%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$321.2K$178.9K
Annual income after 10y$60,965.20$80,797.29
Total dividends collected$251.2K$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst price target$16.50$81.06

Year-by-year: LUMO vs ADC ($10,000, DRIP)

YearLUMO PortfolioLUMO Income/yrADC PortfolioADC Income/yrGap
1← crossover$15,308$4,608.29$10,990$580.36+$4.3KLUMO
2$22,973$6,593.00$12,301$860.26+$10.7KLUMO
3$33,828$9,246.73$14,104$1,298.62+$19.7KLUMO
4$48,921$12,725.11$16,691$2,008.16+$32.2KLUMO
5$69,544$17,198.81$20,580$3,205.09+$49.0KLUMO
6$97,262$22,849.74$26,754$5,330.02+$70.5KLUMO
7$133,936$29,866.21$37,196$9,345.14+$96.7KLUMO
8$181,749$38,437.25$56,244$17,523.09+$125.5KLUMO
9$243,218$48,746.39$94,286$35,736.21+$148.9KLUMO
10$321,208$60,965.20$178,949$80,797.29+$142.3KLUMO

LUMO vs ADC: Complete Analysis 2026

LUMOStock

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

Full LUMO Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this LUMO vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LUMO vs SCHDLUMO vs JEPILUMO vs OLUMO vs KOLUMO vs MAINLUMO vs NNNLUMO vs EPRTLUMO vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.